Fritextsökning
Innehållstyper
-
Lundbeck divests companies
The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.
-
535 miljoner till regenerativ medicin
Knut och Alice Wallenbergs Stiftelse finansierar ett nytt forskningscentrum i Lund.
-
Smarta män tar sin medicin
Generell kognitiv förmåga har visat sig spela roll för hur väl män tar sin ordinerade medicin efter en hjärtinfarkt. Det visar en ny studie från Umeå och Uppsala universitet.
-
Sprint får ny vetenskaplig rådgivare
Cancerforskaren Ravi Amaravadi från USA ska hjälpa bolaget till klinisk fas.
-
Mingling do's and don'ts
Linkedin, Facebook, MSN and Gmail are all perfect tools for the urban businessman or woman to keep track of and stay up-to-date with contacts. "But in the end, ...
-
Få överraskningar i rapporten
Pledpharmas kvartalsrapport bjöd inte på några stora nyheter men planerna på diskussioner med FDA och potentiella samarbetspartners ligger fast.
-
Trio goes in for high tech medicines
The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.
-
Think outside the... brain
Riitta Hari from the Brain Research Unit at the Helsinki University of Technology has recently stated that the mind is more than just the brain.
-
New faces in Pronova Biopharma team
The Norwegian company Pronova Biopharma has recently changed the management team structure.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
Ambassador program makes MVA big in Japan
The first ambassadors of the Medicon Valley Ambassador Programme have only worked in each other's countries for six months. But they have already made a signifi...
-
Biotech goes white and bright
White biotech could become Denmark's next blossoming business area.
-
Släpper aptitretande rapport
Stockholm Business Region släpper rapport om onkologi för att locka investerare till Stockholm-Uppsalaregionen. – Rapporten ska vara en aptitretare, förklarar Ylva Hultman.
-
Grant for development projects in Gothenburg
Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.
-
New tools to fight bacteria
Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...
-
Säkerhetsbrister på barnsjukhus
Knäckte lösenorden till skyddade dokument från prövningar
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
A crash course in IP strategy
"Publish, publish, publish!" Sound familiar? So to meet the researcher's wishes, do you scribble a patent application with lipstick on a napkin and send it in? ...
-
Planerar det regulatoriska arbetet
Anna Törner från SDS ska stötta Lidds med den regulatoriska planen för bolagets läkemedelskandidat mot prostatacancer, där en fas IIb-studie är på gång.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Schizophrenia and bipolar disorder are relatives
Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.
-
Nytt namn i Symphogens ledning
Adriann Sax har utsetts till affärschef på det danska företaget.
-
Academy for a new turn at work
Are you qualified within life science, but unemployed? Here is your chance for a new career, in high demand.
-
Raysearch igång i Kina
Första patienten ombord i strålstudie.